City
Epaper

Delhi Health Minister suggests Centre should float global tender for COVID vaccine instead of states

By ANI | Updated: May 13, 2021 19:30 IST

Delhi Health Minister Satyendar Jain on Thursday said that he has suggested to the Union Health Ministry that the Central government should float a single global tender instead of various states to purchase COVID-19 vaccines.

Open in App

Delhi Health Minister Satyendar Jain on Thursday said that he has suggested to the Union Health Ministry that the Central government should float a single global tender instead of various states to purchase COVID-19 vaccines.

Addressing a press conference, the health minister said if states go to procure vaccines in the international market then it will be an insult for the country.

"I suggested the Health Ministry if the vaccine has to be purchased from foreign countries, then instead of different states floating different global tenders, the Centre should purchase these vaccines on behalf of the states," he said.

"If in the international market, Delhi Uttar Pradesh, Karnataka, Kerala go separately to purchase COVID vaccines, then it will be an insult for the country," he added.

Jain said the two vaccine manufacturing companies in India - Bharat Biotech and Serum Institue of India - should share their formula with other companies in order to increase vaccine production.

"There are two companies producing vaccines in India with the names Covishield and Covaxin. I have requested the Centre the companies should share their formulas, as India has the highest vaccine producing capacity in the world. There are a lot of companies in India that can produce vaccines," he said.

The minister further said, "With this move, these companies can not only fulfil India's demand but also the demand outside of India."

He also said that the companies should not be allowed to sell vaccines for more than Rs 150.

On Thursday, NITI Aayog member Dr V K Paul informed that the central government and Hyderabad-based Bharat Biotech are willing to invite other companies that wish to produce Covaxin, in a bid to scale up vaccine production amid its acute shortfall.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: United StatesdelhiSatyendar JainUnion Health MinistryHealth Ministry`delhiDelhi capitalSouth delhi district administrationIto delhiGhaziabad district administration
Open in App

Related Stories

NationalDelhi: Food Delivery Worker Bullied in Narela, Drunken Customer Misbehaves with Police

NationalZubeen Garg Death Probe: Festival Organiser Shyamkanu Mahanta and Manager Siddhartha Sharma Arrested in Delhi, Brought to Guwahati

NationalIndiGo's Mumbai-Delhi Flight Gets Bomb Threat; Full Emergency Declared At IGI Airport

NationalDelhi News: Three Killed in Suspected Hit-and-Run Accident in Jahangirpuri

NationalDelhi Bomb Threat: Schools and Airport Across City Receive Blast Email; Security Beefed Up at National Capital

National Realted Stories

NationalCentre approves mitigation, recovery and reconstruction projects worth Rs 4645.60 crore

NationalRajasthan: Steady decline in crime over last two years, claims police

NationalMaha: Five Dussehra rallies to be held tomorrow; all eyes on Uddhav Thackeray and Eknath Shinde

NationalCentre grants Rs 260.56 crore for rebuilding Wayanad hit by landslide

National‘Deep insult to freedom struggle’: Congress on honouring RSS